We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PYPL icon
76
PayPal
PYPL
$49.5B
$64.2M 0.31%
822,324
+13,342
+2% +$892K
ACWX icon
77
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$63.7M 0.3%
1,113,656
-12,426
-1% -$677K
SCHW
78
Charles Schwab
SCHW
$180B
$63.7M 0.3%
982,156
-10,855
-1% -$713K
SHW icon
79
Sherwin-Williams
SHW
$80.7B
$62.4M 0.3%
163,454
-2,522
-2% -$880K
AMGN icon
80
Amgen
AMGN
$203B
$61.3M 0.29%
190,395
-42,532
-18% -$13.9M
FTNT icon
81
Fortinet
FTNT
$111B
$59.4M 0.28%
766,184
-192,991
-20% -$13.2M
CL icon
82
Colgate-Palmolive
CL
$73.4B
$58.7M 0.28%
565,831
-6,500
-1% -$662K
EBAY icon
83
eBay
EBAY
$50.1B
$58.4M 0.28%
896,906
-385,788
-30% -$22.2M
TMO icon
84
Thermo Fisher Scientific
TMO
$209B
$55.3M 0.26%
89,433
-6,486
-7% -$3.84M
AVGO icon
85
Broadcom
AVGO
$1.8T
$53.5M 0.26%
310,009
-7,081
-2% -$1.14M
IJT icon
86
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.21B
$53.3M 0.25%
381,829
-2,631
-0.7% -$355K
MLM icon
87
Martin Marietta Materials
MLM
$34.3B
$51.1M 0.24%
94,947
-3
-0% -$1.62K
QUAL icon
88
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
$50.4M 0.24%
280,978
+23,542
+9% +$4.08M
DOCU
89
DocuSign
DOCU
$10.3B
$49.3M 0.24%
793,301
+175,952
+29% +$9.86M
BMY icon
90
Bristol-Myers Squibb
BMY
$128B
$48.8M 0.23%
943,271
-296,440
-24% -$13.9M
CAT icon
91
Caterpillar
CAT
$392B
$48.7M 0.23%
124,477
-140
-0.1% -$48.3K
GLD icon
92
SPDR Gold Trust
GLD
$132B
$48.1M 0.23%
197,830
+3,138
+2% +$719K
DT icon
93
Dynatrace
DT
$12.7B
$47.3M 0.23%
883,885
+33,013
+4% +$1.57M
ELV icon
94
Elevance Health
ELV
$82B
$47.2M 0.23%
90,700
-36,028
-28% -$19.2M
TT icon
95
Trane Technologies
TT
$105B
$47.1M 0.23%
121,117
+407
+0.3% +$141K
UPS icon
96
United Parcel Service
UPS
$96.3B
$47M 0.22%
344,609
-6,709
-2% -$881K
INCY icon
97
Incyte
INCY
$23.8B
$46.1M 0.22%
697,025
-156,962
-18% -$10M
COR icon
98
Cencora
COR
$60.7B
$44.1M 0.21%
195,871
+140,641
+255% +$32.7M
TWLO icon
99
Twilio
TWLO
$29.6B
$43.7M 0.21%
669,938
+15,519
+2% +$929K
OMC icon
100
Omnicom Group
OMC
$23.6B
$42.1M 0.2%
406,783
-13,941
-3% -$1.34M
2 3
4
5 6

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.